Skip to main content

Table 1 Final diagnoses, patient characteristics, needle type used, and cases in which TBNA was the only technique that permitted the diagnosis.

From: Validity and reliability of transbronchial needle aspiration for diagnosing mediastinal adenopathies

Pathology Patients, n (%) Age# in years Male, n (%) Cytology needle, n (%) Unique diagnostic, n (%)
Non-small cell lung carcinoma 280 (48.3%) 62.0 (42-87) 221 (79.5%) 262 (93.6%) 96 (34.2%)
Small cell lung carcinoma 74 (12.8%) 65.0 (34-89) 62 (83.8%) 62 (83.8%) 30 (40.5%)
Extrapulmonary carcinoma+ 44 (7.6%) 61.5 (26-81) 21 (47.7%) 34 (77.3%) 16 (36.3%)
Sarcoidosis 57 (9.8%) 39.5. (21-75) 29 (58.9%) 4 (7.0%) 20 (35.1%)
Tuberculosis 19 (3.3%) 58.0 (38-79) 11 (57.9%) 3 (15.8%) 8 (42.1%)
Lymphoma 15 (2.6%) 66.0 (29-81) 7 (46.7%) 3 (20.0%) 4 (26.7%)
Anthracotic and reactive 91 (15.7%) 63.0 (21-85) 71 (78.0%) 46 (50.5%) 11 (12.1%)
Total 580 62.0 (21-89) 422 (72.8%) 414 (71.4%) 214 (31.8%)
  1. #Data are presented as median (range).
  2. 130 adenocarcinomas, 83 large-cell undifferentiated carcinomas, 67 squamous cell carcinomas.
  3. +13 breast, 10 renal, 5 larynx, 4 colon, 3 gastric, 2 hepatocarcinoma, 2 prostate, 1 endometrium, 1 ovary, 1 bladder, 1 thymus, 1 esophagus.